Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion. [electronic resource]
- Toxicology and applied pharmacology Oct 2014
- 10-20 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2014.07.018 doi
Animals Anoikis--drug effects Breast Neoplasms--drug therapy Cell Line, Tumor Cell Movement--drug effects Chalcones--pharmacology Cyclooxygenase 2--metabolism Cytochrome P-450 CYP4A--antagonists & inhibitors Down-Regulation--drug effects Enzyme Inhibitors--pharmacology Female Glycyrrhiza Humans Mice Mice, Inbred BALB C Mice, Nude Neoplasm Invasiveness--prevention & control Plant Extracts--isolation & purification Random Allocation Signal Transduction--drug effects Xenograft Model Antitumor Assays--methods